Syngulon’s Post

Excited to be attending the #STATBreakthrough Summit East today! With sessions moderated by STAT’s award-winning journalists ✍🏼, it's sure to be a stimulating 💡 day of learning from patients, providers, and biopharma leaders. Looking forward to gaining insights on patient advocacy 📣, health tech 👩🏻💻, biotechnology 🧑🔬, and drug development 💊. Follow along for updates! #patientadvocacy #healthtech #biotechnology #drugdevelopment

Accelerate breakthroughs. Unleash life-saving therapies. At Bios Health Group, we're not just a partner; we're your strategic ally in the journey of life sciences innovation. Our mission? To empower biotech and life science visionaries like you to turn groundbreaking ideas into reality. 🌱 Whether you're a pioneering company or an investor with a passion for progress, we've got your back every step of the way. Let's revolutionize healthcare together! www.bioshealthgroup.com #biotechnology #clinicaldevelopment #drugdevelopment #biotech  #BiosHealthInnovates #HealthcareRevolution #InnovationJourney #CollaborateForChange #ClinicalTrialsAdvancement #PatientDiversity  #LifeSciences #Biotech #Innovation #Healthcare #Research #Biomedical #MedTech #Investment #Science #Tech #HealthTech #Pharma

🔬 Implementing alternative methods for adventitious agents can slash >90% of testing time and realize cost savings of up to $5 million per product , but their adoption has been slow. 📰 The BioPhorum paper ‘A Structured Approach For The Evaluation, Validation And Implementation Of Nat-Based Mycoplasma Detection Methods’, published in 2023 by the Technology Strategy Phorum has been summarised by Life Science Connect and details a best practice 9 step framework for adoption of NAT-Based Mycoplasma Detection Methods. #Mycoplasma #BioPhorum Life Science Connect Bioprocess Online https://lnkd.in/e7TM-7Tg ✍🏻 Authors: ✍🏾 ·      BioMérieux Félix A MONTERO-JULIAN PhD ·      Lonza Antonietta Corrado, Eva Tur García ·      Merck (Health Care Business Sector) Cristina Barbirato ·      Merck (Life Science Business Sector) Rob Goodier , Donna McMutrie ·      Novo Nordisk Annette Jørgensen ·      Pall Biotech Morven McAlister ·      Roche/Genentech Sven Deutschmann, Kevin McCarthy ·      Sanofi Thierry Bonnevay ·      Sartorius Stedim Dr. Miriam Dormeyer ·      Thermo Fisher Scientific Mike Brewer ☑ Reviewers: ☑ ·      Asahi Kasei Daniel Strauss ·      BioMérieux Philippe GADAL, Arnaud PARIS - Pharma Quality Control ·      Bioprocessing Technology Institute, Agency for Science, Technology and Research Andre Choo ·      FUJIFILM Diosynth Biotechnologies WILLIAMS KWAME NKRUMAH, LLM ·      Janssen Karen De Roy ·      Novo Nordisk Corinna Cavan Pedersen

The article "What to watch in the life sciences in 2024" by Clarivate provides insights into upcoming trends and developments in the life sciences industry. It offers a preview of key areas to monitor for advancements and innovations in the field. Subjects discussed include emerging technologies that are poised to revolutionize drug development processes, anticipated market trends and shifts in the life sciences sector, regulatory updates and potential changes that could impact drug development and approval processes, and growing importance of patient-centric innovation in the life sciences. KSB is dedicated to advancing impactful therapies that address critical healthcare challenges by staying abreast of industry developments and embracing innovative approaches. Article link: https://lnkd.in/gcXNnTQU #LifeSciencesTrends #DrugDevelopment #MedicalInnovations #Biotech

𝗧𝗵𝗲𝘀𝗲 𝗮𝗿𝗲 𝟯 𝗳𝗮𝗰𝘁𝘀 𝘆𝗼𝘂 𝗵𝗮𝘃𝗲 𝗻𝗲𝘃𝗲𝗿 𝗵𝗲𝗮𝗿𝗱 𝗮𝗯𝗼𝘂𝘁 𝗣𝗛𝗔𝗕𝗜𝗢𝗖 𝗮𝗻𝗱 𝘀𝘁𝗶𝗹𝗹 𝗻𝗲𝗲𝗱 𝘁𝗼 𝗸𝗻𝗼𝘄 🤯👨🔬 At PHABIOC, we’re passionate about pushing the boundaries of laboratory innovation. Here are three lesser-known facts about us that highlight our commitment to excellence and sustainability: 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 𝗳𝗼𝗿 𝗘𝘁𝗵𝗶𝗰𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵: Our #PermeaPad is designed to reduce reliance on animal testing by providing an effective in vitro method to predict in vivo bioavailability. This not only speeds up your research but also supports ethical practices in pharmaceutical development. 𝗦𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗮𝘁 𝗢𝘂𝗿 𝗖𝗼𝗿𝗲: We’re committed to reducing waste in the lab. Using our #SpecPlate can cut down your lab waste by up to 72%, contributing to a more sustainable research environment while also boosting your workflow efficiency by 35%. 𝗢𝗽𝗲𝗻 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗔𝗽𝗽𝗿𝗼𝗮𝗰𝗵: Our open innovation approach fosters collaboration and knowledge sharing, leading to our advanced technology transfer concept. We work closely with partners and researchers to ensure our innovations are seamlessly integrated into their workflows, maximizing impact and efficiency. Discover how PHABIOC can transform your lab with our innovative and sustainable products. Let’s work together to drive forward the future of research! #PHABIOC #LabInnovation #Sustainability #EthicalResearch #OpenInnovation

𝗧𝗶𝗿𝗲𝗱 𝗼𝗳 𝗴𝗲𝗻𝗲𝗿𝗶𝗰 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗲𝘃𝗲𝗻𝘁𝘀? Experience the 𝗣𝗿𝗼𝘃𝗲𝗻𝘁𝗮 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝗰𝗲𝗅 Proventa roundtables offer 𝗱𝗲𝗲𝗽 𝗱𝗶𝘃𝗲𝘀 𝗶𝗻𝘁𝗼 𝗰𝗿𝗶𝘁𝗶𝗰𝗮𝗹 𝗶𝘀𝘀𝘂𝗲𝘀 and 𝗵𝗶𝗴𝗵-𝗶𝗺𝗽𝗮𝗰𝘁 𝗻𝗲𝘁𝘄𝗼𝗿𝗸𝗶𝗻𝗴. Join top leaders in Pharma & Biotech for candid discussions and lasting connections. 𝗕𝗲𝘆𝗼𝗻𝗱 𝗴𝗲𝗻𝗲𝗿𝗶𝗰 𝗻𝗲𝘁𝘄𝗼𝗿𝗸𝗶𝗻𝗴: Mingle with C-Suite execs, leading researchers, and key decision-makers. Spark new opportunities and fuel your career. 𝗗𝗲𝗲𝗽 𝗱𝗶𝘃𝗲𝘀, 𝗻𝗼𝘁 𝘀𝘂𝗿𝗳𝗮𝗰𝗲 𝘁𝗮𝗹𝗸: Tackle pressing issues in Drug Discovery & Clinical Operations. Expert-led discussions. Diverse perspectives. Actionable insights. 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝘁𝗵𝗮𝘁 𝗱𝗿𝗶𝘃𝗲 𝗰𝗵𝗮𝗻𝗴𝗲: Collaborate with peers on real-world solutions. Shape the future of Pharma & Biotech. Don't miss the upcoming Strategy Meetings! 𝗟𝗼𝗻𝗱𝗼𝗻 October 22 - Drug Discovery & Bioinformatics October 23 - Medicinal Chemistry 𝗕𝗼𝘀𝘁𝗼𝗻 November 11 - Bioinformatics November 12 - Drug Discovery November 13 - Medicinal Chemistry November 14 - Clinical Operations & Clinical Trials Supply Chain #ProventaStrategy #ExecutiveRoundtables #PharmaBiotech #Innovation #Collaboration #IndustryImpact

🚀 Revolutionize Your Immunoprecipitation (IP) Workflows! 🧬 In my latest video, I introduce ChromoTek Nano-Traps from Proteintech Group—your ultimate solution for fast and reliable #protein interactions. If you’re looking for a tool that can help you achieve clean, single-band pulldowns, especially with low-expression proteins, Nano-Traps are here to make a difference. 🎯 Why Nano-Traps? ✅ No heavy or light antibody chains—less noise, more specific results! ✅ High affinity for low-expression proteins. ✅ Stringent washing conditions for cleaner data. ✅ Quick incubation times (just 30-60 minutes!). These ready-to-use affinity beads are the gold standard in: Immunoprecipitation (IP) & Co-IP Mass spectrometry (Co-IP/MS) On-bead assays ChIP/RIP analysis Protein-protein interaction studies (Split-Fluorescent Protein assays) 💥 And don’t miss United Bioresearch Products October #promotion: Buy 2, Get 1 Free on all ChromoTek Nano-Traps in #Australia! It’s the perfect time to stock up on these game-changing tools. Watch the #video for more details, and feel free to reach out with any questions or to take advantage of this limited-time offer! #Proteintech #NanoTraps #Immunoprecipitation #ResearchTools #LifeScience #Biotech #LabSolutions #Promotion #IPexperiments

Discover precision in biotechnology with Solomon Park Research Labs. Our customizable quality control materials ensure accurate clinical test results, aiding medical professionals in patient care. Book your consultation now: https://ow.ly/pLB350ScQ7S #QualityControl #Biotechnology #SolomonParkResearchLab #ClinicalTesting #HealthcareTechnology #BiotechResearch

Hey Connections!!! Skills for Success: Navigating Careers in Biotechnology, Healthcare, and Beyond. Attended an insightful webinar on shaping careers in biotechnology, healthcare, and related fields. The speaker shared invaluable strategies and inspired us to aim higher in our professional journeys. A big thank you to ICT Academy for organizing this impactful session. Grateful for the opportunity to learn and grow! #Biotechnology #Healthcare #ICTAcademy #ksrct1994

If I had to boil it down to a single driving factor for T2B, this would be it: elevating our profession as biopharma communicators. Coming off the heels of #ASGCT2024, as an example where these conversations are happening, we’re starting to talk about a world where genetic diseases are not only cured but preempted. However, the reality is that said world in which we’re operating is also: -Highly polarized and politicized -Has challenging historical context (e.g. Henrietta Lacks, to name just one area) -Filled with mis-, dis-, and malinformation -Is emotionally charged and in some corners, incredibly skeptical (e.g. COVID/vaccines) -Plagued with too much automated content -Entering a new AI era akin to the dawn of the internet We’ve got our work cut out for us, for sure, but bringing this month’s #TicketToBiotech theme full circle to where we started, this is truly one of the most humbling yet gratifying professions out there.